Stock Why Tesla stock is down over 2% on Monday by February 23, 2026 by February 23, 2026 Tesla stock declined at the start of the new trading week, as investors assessed intensifying… 0 FacebookTwitterPinterestEmail
Stock Eli Lilly bets on multi-dose Zepbound pen in GLP-1 retention push by February 23, 2026 by February 23, 2026 Millions of people on GLP-1 weight-loss drugs know the weekly routine by heart: a new… 0 FacebookTwitterPinterestEmail
Stock US stocks open flat after Trump raises global tariffs to 15% by February 23, 2026 by February 23, 2026 US equities were little changed on Monday after President Donald Trump announced an increase in… 0 FacebookTwitterPinterestEmail
Stock Almirall profit quadruples in 2025 as dermatology fuels growth push by February 23, 2026 by February 23, 2026 Almirall, a pharmaceutical firm based in Spain, ended 2025 with a net profit of €46.2… 0 FacebookTwitterPinterestEmail
Stock Vanda stock’s explosive rally may be more hype than substance by February 23, 2026 by February 23, 2026 Vanda Pharmaceuticals (NASDAQ: VNDA) opened some 45% higher today after the biotech firm said it… 0 FacebookTwitterPinterestEmail
Stock Why is Nvidia stock soaring before Q4 earnings? Here’s $65.9B reason by February 23, 2026 by February 23, 2026 Nvidia stock (NASDAQ: NVDA) ticked higher on Monday as Wall Street headed into the chipmaker’s… 0 FacebookTwitterPinterestEmail
Stock Why is Arcellx stock up 80% today? Gilead’s $7.8B answer by February 23, 2026 by February 23, 2026 Arcellx stock (NASDAQ: ACLX) climbed roughly 80% in premarket trade on Monday after Gilead Sciences… 0 FacebookTwitterPinterestEmail
Stock Finland’s IQM leads Europe’s quantum push with US listing plan by February 23, 2026 by February 23, 2026 Finland’s IQM is positioning itself at the centre of Europe’s quantum technology ambitions as it… 0 FacebookTwitterPinterestEmail
Stock We predicted the Blue Owl stock price crash to $10 by February 23, 2026 by February 23, 2026 Blue Owl stock price has crashed in the past few months, turning one of the… 0 FacebookTwitterPinterestEmail
Stock Merck creates separate oncology arm ahead of Keytruda patent loss by February 23, 2026 by February 23, 2026 Merck said on Monday that it will split its human-health operations into two separate divisions,… 0 FacebookTwitterPinterestEmail